LabGenius logo

LabGenius

Synthetic biology company that uses AI, DNA synthesis, and robotics to discover biological molecules.

8

Funding Rounds

$101.4m

Money raised

Overview

Synthetic biology company that uses AI, DNA synthesis, and robotics to discover biological molecules.

Funding

Funding series

Funding Series Analysis

The company LabGenius has raised a total of $82.7m in funding over 8 rounds.

Key Insights:

  • LabGenius May 2024 Series B Funding Round: $44m
  • LabGenius , November 2020: $15m
  • LabGenius Series A round, October 2019: $10m
  • LabGenius October 2019 Series A Funding Round: $10m
  • LabGenius November 2017 Seed Funding Round: $3.7m
  • LabGenius Series A round, October 2020: $15m
  • LabGenius Seed round, November 2017: $3.7m
LabGenius logo
LabGenius May 2024 Series B Funding Round $44m
LabGenius logo
LabGenius , November 2020 $15m
LabGenius logo
LabGenius Series A round, October 2019 $10m
LabGenius logo
LabGenius October 2019 Series A Funding Round $10m
LabGenius logo
LabGenius November 2017 Seed Funding Round $3.7m
LabGenius logo
LabGenius Series A round, October 2020 $15m
LabGenius logo
LabGenius Seed round, November 2017 $3.7m

Industries

LabGenius is active in the following industries:
  • Machine learning
  • Artificial Intelligence (AI)
  • Robotics
  • Automation
  • Drug discovery
  • Biomedical engineering
  • Engineering
  • Synthetic biology
  • Biology
  • Technology
  • Biotechnology
  • Manufacturing
  • Health technology
  • Deep Tech